Background: The endovascular therapy for cerebral venous sinus thrombosis (CVST) is currently accepted as a second-line treatment for patients who have failed or those in whom systemic anticoagulation is contraindicated or in a subgroup of patients presenting with rapid neurologic deterioration. A number of different mechanical and pharmacologic endovascular strategies have been reported, either as separate or combined approaches. These new catheters and aspiration systems have a high power and vacuum capacity, which carries a risk of anemization of the patient and hypovolemic shock, being necessitating the transfusion of the patient. Material and methods: Because of the problems that donor blood transfusion can bring, we describe the use of a Sorin Xtra Õ Autotransfusion System (ATS). This complete autologous blood recovery system was designed for use in procedures where medium-to high-volume blood loss occurs, such as major surgeries. We have adapted it to recover all the blood aspirated during the mechanical thrombectomy procedures of the dural cerebral venous sinuses, since they are procedures that can cause a significant loss of blood. One advantage to this is the patient receives his or her own blood instead of donor blood, so there is no risk of contracting outside diseases or transfusion reactions. Conclusions: This technical note describes a novel and previously unpublished technical approach to CVST that can be immediately applied to clinical practice. It also raises awareness among the interventional neuroradiologist and anesthesiologist communities about novel, potentially lifesaving endovascular treatments in patients with extensive CVST.
Introduction
The endovascular therapy for cerebral venous sinus thrombosis (CVST) is currently accepted as a secondline treatment for patients who have failed or those in whom systemic anticoagulation is contraindicated 1 or in a clinically identifiable subgroup of patients presenting with rapid neurologic deterioration. 2 A number of different mechanical and pharmacologic endovascular strategies have been reported, either as separate or combined approaches. [3] [4] [5] The newest-generation thrombectomy devices designed for arterial recanalization in acute ischemic stroke, including the Penumbra Õ aspiration system (Penumbra, Alameda, CA, USA), 6, 7 the Solitaire TM thrombectomy device (Covidien Neurovascular, Irvine, CA, USA), 8, 9 and the Trevo Õ thrombectomy device (Stryker-Concentric Medical Inc, Mountain View, CA, USA), 10 have also been used with acceptable safety and efficacy in venous sinus thrombosis. [11] [12] [13] These new catheters and aspiration systems have a high power and vacuum capacity, which carries a risk of anemization of the patient and hypovolemic shock, necessitating the transfusion of the patient.
Because of the problems that donor blood transfusion can bring, we describe the use of a Sorin Xtra Õ Autotransfusion System (ATS) (Sorin Group Deutschland GMBH, Mu¨nchen, Germany). This complete autologous blood recovery system was designed for use in procedures where medium-to high-volume blood loss occurs, such as major surgeries. We have adapted it to recover all the blood aspirated during mechanical thrombectomy (MT) procedures of the dural sinuses, since there are procedures that can cause a significant loss of blood. A significant advantage of this procedure is that the patient receives his or her own blood instead of donor blood, so there is no risk of contracting outside diseases.
Material and methods

Problem case (case report 1)
A 62-year-old woman with a history of high blood pressure, lipid and depressive disorders, and acute otitis media with tympanic membrane perforation one to two months before admission presented with sudden headache, nausea, vomiting, right brachial weakness, and speech disturbance, National Institutes of Health Stroke Scale (NIHSS): 7. A non-contrast head computed tomography (CT) scan demonstrated increased attenuation within the right transverse sinus, the superior sagittal sinus (SSS) and few cortical veins, associated with bilateral hematomas and edema ( Figure 1 ). Subsequent multimodal magnetic resonance imaging (MRI) confirmed the diagnosis of right transverse sinus and SSS thrombosis. The patient was treated medically with hydration, anticoagulation and antiepileptic drugs. However, she became more lethargic over the next 24 hours and follow-up imaging demonstrated progression of her thrombosis with worsened bilateral edema. Given the progressive thrombosis and clinical deterioration despite maximum medical therapy, a decision was made to proceed with endovascular intervention. The initial diagnostic angiogram demonstrated a near complete occlusion of the right transverse sinus, the anterior two-thirds of the SSS as well as occlusion within some cortical veins with associated severely delayed arteriovenous transit time (Figure 2 (a)). MT was performed with the technique described below. The final post-intervention angiogram revealed almost complete recanalization of the previously occluded sinuses with some residual venous thrombosis and significantly improved After the intervention, a serious problem arose because the patient developed hypovolemic shock, which required transfusion.
With this patient we learned the following several lessons:
. Today, we have technology capable of sucking and removing thrombus with high power. . This high suction capacity can cause anemia and hypovolemic shock. . Therefore, a recovery system of the patient's blood is required.
Demonstration cases after the lesson received Case report 2. A 21-year-old male was admitted to the intensive care unit (ICU) after severe head injury with an initial Glasgow Scale Score (GCS) of 3, who had a skull base fracture with jugular foramen and carotid canal involvement, and diffuse cerebral swelling with intracranial hypertension (ICH), requiring urgent neurosurgical treatment by decompressive craniectomy (DC). Because of the persistence of ICH despite DC, CT angiography was performed that revealed the presence of thrombosis in the transverse and sigmoid sinuses and in the right internal jugular vein, probably secondary to direct trauma on the aforementioned venous structures underlying the described fracture lines. Given the severe cranioencephalic trauma and recent surgery that contraindicated anticoagulation as a recommended first-line treatment in case of CVST, we chose to perform MT with the technique we will describe. Complete cerebral venous reperfusion was achieved, with no incidences during the procedure, and with improvement of intracranial pressure (ICP). During the procedure the patient's blood was recovered and autotransfusion was performed (Figures 3-7) .
Case report 3. A 55-year-old man suffered a generalized tonic-clonic seizure with traumatic brain injury (TBI) in a context of loss of consciousness. The initial non-contrast head CT scan showed left frontal hematoma with adjacent subarachnoid hemorrhage. To complete the study, MRI was performed, which revealed thrombosis of the SSS, a left frontal cortical vein and both transverse sinuses. Anticoagulant treatment was started with sodium heparin in perfusion, despite which, he presented with poor clinical evolution. The new non-contrast head CT scan showed signs of left frontal rebleeding that caused midline shift. He required neurosurgical treatment by performing DC with hematoma evacuation. Due to the contraindication of restarting anticoagulation, it was decided to Figure 6 . This photo shows the cell salvage machine, Sorin Xtra Õ Autotransfusion System (ATS) (Sorin Group Deutschland GMBH, München, Germany), filtering, washing, and processing the patient's own blood to be recovered and administered back to the patient. perform MT, with the same technique described below, with good result with reduction of ICP after the procedure, without associated complications. During the procedure the patient's blood was recovered and autotransfusion was performed with the same technique described.
MT procedure
Using a transfemoral approach, with the Seldinger technique, a 5-Fr catheter is placed in the internal carotid artery for diagnosis and control angiograms.
By transfemoral venous access a 90 cm 6 Fr shuttle sheath (Neuron TM MAX 088, 6F long sheath, Penumbra, Alameda, CA, USA) was inserted in the internal jugular vein (Figure 2(b) , arrow c). Next, an ACE64 Õ Penumbra Õ reperfusion catheter (Penumbra, Alameda, CA, USA) was navigated within the anterior portion of the sinus thrombosis over a coaxially inserted Rebar 18 microcatheter (Medtronic-Covidien, Minneapolis, MN, USA) and Synchro 14 microguidewire (Stryker Neurovascular, Fremont, CA, USA) (Figure 2(b) , arrow b). A Solitaire TM FR 2 6 Â 30 mm clot retrieval device ((Medtronic-Covidien, Minneapolis, MN, USA) was then deployed in the anterior portion of the thrombosed sinus (Figure 2(b) , arrow a). The Solitaire TM FR2 was then pulled into the ACE64 Õ catheter, which was connected to the Penumbra Õ aspiration system. Using the same technique, several sequential passes from the proximal to the distal aspect of the sinus were made with a Solitaire TM FR2 6 Â 30 mm under continuous aspiration via the ACE64 Õ catheter, which remained positioned within the sinus. Large clot fragments were removed from the Solitaire TM 2 and ACE64 Õ catheter after each pass ( Figure 5 ).
Additional clot aspiration throughout the thrombosed sinus was performed through the Penumbra Õ ACE64 Õ catheter if required. Although there was antegrade flow in the sinus, if some residual wall adherent thrombus was appreciated in the sinus it was targeted with more pulls with the Solitaire TM 6 Â 30 mm device while aspirating via the ACE64 Õ catheter.
A final post-intervention angiogram was performed to confirm the recanalization of the previously occluded sinus and significantly improved arteriovenous transit time (Figures 2(c) and (d) ).
Use of a Sorin Xtra Õ ATS (complete autologous blood recovery system)
The intraoperative cell salvage machine Sorin Xtra Õ Autotransfusion System (ATS) (complete autologous blood recovery system) (Sorin Group Deutschland GMBH, Mu¨nchen, Germany) is connected to the Penumbra Õ suction system. This system suctions, washes, and filters the blood so it can be given back to the patient's body through a peripheral vein, instead of being thrown away. During the process, plasma, toxic products (produced by hemolysis), coagulation factors, platelets and fat are eliminated. All this is regulated by a microprocessor with internal air detectors and unidirectional valves.
The clinical perfusionist (in our case the nurse and the anesthesiologist) must have received specific training.
Strict aseptic technique must be maintained at all times.
The relative contraindications to cell salvage 14 are described in Table 1 .
Our indications, method and way of use are as follows:
In all mechanical venous sinus thrombectomy procedures we use this device to prophylactically collect the extracted blood and have it available for administration if necessary. This is motivated by the fact that blood loss of >500 ml or >20% of the total blood volume is expected and blood loss cannot be predicted.
All patients are periodically tested for hemoglobin. The frequency is determined by the amount of blood drawn and the conditions of the patient.
Blood transfusion is not performed if hemoglobin is >10 g/dl.
Young people with no concomitant pathologies are transfused if hemoglobin is <8 g/dl.
People with concomitant pathologies (such as ischemic heart disease) are transfused if hemoglobin is <10 g/dl. Figure 7 . This photo shows how this system has sucked, washed, filtered and processed the blood so this blood can be given back to the patient's body through a peripheral vein, instead of being thrown away.
Discussion
Despite the overall favorable outcome with systemic anticoagulation, CVST can be potentially devastating, particularly in a clinically identifiable subgroup of patients presenting with rapid neurologic deterioration. 2 The severity of the clinical symptoms is proportional to the degree of vasogenic and cytotoxic edema secondary to compromised venous collateral flow, particularly in cases with cortical venous extension. [15] [16] [17] These pathophysiologic changes can lead to fatal herniation, sometimes requiring lifesaving DC. 18 While the therapeutic effect of systemic anticoagulation is mainly to prevent thrombus propagation, endovascular intervention can lead to immediate revascularization and restoration of normal venous flow. 11 As such, MT has been proposed as a first-line approach for CVST. 19 Papers with acceptable safety and efficacy in venous sinus thrombosis have been published. [11] [12] [13] The problem is that these new catheters and aspiration systems have a high power and vacuum capacity, which carries a potential risk of anemization of the patient and hypovolemic shock, necessitating a blood transfusion, as we described in one of our patients.
Because of the problems that donor blood transfusion can bring, we decided to recover the patient's blood for autotransfusion and describe the use of a complete autologous blood recovery system, the Sorin Xtra Õ Autotransfusion System (ATS) (Sorin Group Deutschland GMBH, Mu¨nchen, Germany).
The Sorin Xtra Õ Autotransfusion System (ATS) (Sorin Group Deutschland GMBH, Mu¨nchen, Germany) is designed with an easy-to-use, reliable way to recover and deliver back a patient's own highquality blood during medium to high blood loss procedures, such as major surgeries. The system provides patients with their own fresh, washed blood, preventing an allogeneic transfusion while helping to reduce costs. Its integrated smart suction is gentle on red blood cells (RBCs), preserving them for transfusion. With the ability to deliver moderate hematocrit and to help remove traces of undesirable components such as free hemoglobin (dual RBC detector technology delivers the highest RBC hematocrit), the system is the standard of care for participating hospitals and is a critical tool to help avoid unnecessary allogeneic transfusions and an effective fat particle elimination (the new Pfat protocol removes more than 99% of lipid particles from processed blood), mitigating potential risk of fat embolism and is designed for optimal performance, while still offering custom settings that allow for modifications during procedures. 20 One advantage to this is the patient receives his or her own blood instead of donor blood, so there is no risk of contracting outside diseases or transfusion reactions (fever, chills, pruritus, urticaria, severe shortness of breath, red urine, loss of consciousness, etc.).
An important aspect to consider is that removing blood during MT causes suction to pass through a catheter, and there was negative pressure throughout the thrombectomy system. Therefore, although the RBC size is much smaller than that used with catheters, hemolysis may occur. In the analyses that we have performed, we have not found an increase in hemolysis, but it is clear that further studies are needed to corroborate this aspect.
Conclusions
This technical note describes a novel and previously unpublished technical approach to CVST that can be immediately applied to clinical practice. It also raises awareness among the interventional neuroradiologist and anesthesiologist communities about novel, potentially lifesaving endovascular treatments in patients with extensive CVST.
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